St. Jude Children's Research Hospital: Mapping Genetic Variants Driving Toxicity to Leukemia Therapy
February 25, 2020
February 25, 2020
MEMPHIS, Tennessee, Feb. 25 -- St. Jude Children's Research Hospital issued the following news release:
Scientists at St. Jude Children's Research Hospital, alongside collaborators around the world, have created a comprehensive reference of functional variants in an important drug-metabolizing enzyme called NUDT15. This thorough understanding of NUDT15 variants provides an invaluable resource for predicting which patients being treated with thiopurine drugs for acute lymphoblastic l . . .
Scientists at St. Jude Children's Research Hospital, alongside collaborators around the world, have created a comprehensive reference of functional variants in an important drug-metabolizing enzyme called NUDT15. This thorough understanding of NUDT15 variants provides an invaluable resource for predicting which patients being treated with thiopurine drugs for acute lymphoblastic l . . .